Pharma Journalist -

Roche has announced that the U.S. Food and Drug Administration (FDA) has approved the combination of Tecentriq® (atezolizumab) and Tecentriq Hybreza® (atezolizumab and…
Read More...

Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to BMS-986446, a promising anti-microtubule binding region-tau…
Read More...

Taysha Gene Therapies announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to TSHA-102, its intrathecally delivered AAV9 gene therapy…
Read More...

Halozyme Therapeutics has announced a definitive agreement to acquire Elektrofi, a biopharmaceutical company known for its breakthrough ultra-high concentration biologics delivery…
Read More...

Takeda Pharmaceutical Company has announced it will discontinue its cell therapy research and development efforts as part of a broader strategic portfolio prioritization. The company…
Read More...

Star Therapeutics has announced the closing of an oversubscribed $125 million Series D financing round to accelerate the development of its pipeline of antibody-based therapies,…
Read More...

Klotho Neurosciences, Inc. has announced it has signed a Letter of Intent (LOI) to acquire select assets from Turn Biotechnologies, Inc., a pioneer in cellular reprogramming and induced…
Read More...

Pfizer has announced a historic agreement with the Trump Administration aimed at significantly reducing prescription drug prices for American patients while reinforcing the U.S.'s…
Read More...

AbbVie has broken ground on a $70 million expansion of its AbbVie Bioresearch Center (ABC) in Worcester, Massachusetts, a key hub for the company’s biologics research, development, and…
Read More...

BioLineRx Ltd. and Norwegian biotech Hemispherian AS have established a joint venture to develop GLIX1, a first-in-class oral small molecule designed to target DNA damage response in…
Read More...